Enterococcus faecalis Urinary Tract Infection Antibiotic Choice
Meropenem can have activity against Enterococcus faecalis, but it is not a standard preferred option for enterococcal urinary tract infection when the isolate is susceptible. [1]
Susceptibility-Driven Feasibility of Meropenem
Imipenem and, to a lesser degree, meropenem are active against E. faecalis. [1]
Standard Therapy When Isolate Is Susceptible
Urinary tract infections caused by enterococci generally do not require bactericidal therapy. [1]
If the causative E. faecalis isolate is susceptible, treatment is typically with a single agent such as ampicillin or amoxicillin. [1]
Nitrofurantoin and fosfomycin are also effective options for lower urinary tract infection (eg, cystitis) when appropriate to site of infection and susceptibility. [1]
When Meropenem Is Considered
Meropenem may be used when susceptibility supports activity and narrower active agents cannot be used because of clinical context or resistance patterns. [1]
Meropenem is used more commonly for other resistant Gram-negative pathogens or polymicrobial infections rather than as routine enterococcal cystitis therapy. [1]
Practical Points for Culture-Directed De-escalation
Antibiotic selection should be guided by urine culture susceptibilities for the E. faecalis isolate. [1]
If susceptibilities support ampicillin or amoxicillin activity, these options are typically favored over carbapenem therapy for uncomplicated enterococcal urinary tract infection. [1]